The Weekly Post

Retatrutide: The Triple-Threat Fat Loss Peptide That Makes Ozempic Look Like a Warm-Up (2026 Guide)

Retatrutide: The Triple-Threat Fat Loss Peptide That Makes Ozempic Look Like a Warm-Up (2026 Guide)

Retatrutide: The Triple-Threat Fat Loss Peptide That Makes Ozempic Look Like a Warm-Up (2026 Guide)BioHack Agent
Published on: 02/03/2026

Retatrutide is a triple agonist targeting GLP-1, GIP, and glucagon. Phase 3 data shows 28.7% weight loss — nearly double Ozempic. This guide covers mechanisms, clinical trials, dosing, side effects, comparison to every weight loss drug, and FDA timeline.

Peptides
Read more